QRFPR

Chr 4

pyroglutamylated RFamide peptide receptor

Also known as: AQ27, GPR103, SP9155

The QRFPR protein functions as a G protein-coupled receptor for the orexigenic neuropeptide QRFP, modulating adenylate cyclase activity and intracellular calcium levels. Mutations in this gene cause autosomal recessive congenital hypogonadotropic hypogonadism, which presents with delayed or absent puberty and reproductive dysfunction. The gene shows extremely high constraint against loss-of-function variants (pLI near 1.0), indicating that complete loss of protein function is poorly tolerated.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
5
Pubs (1 yr)
20
P/LP submissions
0%
P/LP missense
1.45
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryQRFPR
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
20 unique Pathogenic / Likely Pathogenic· 61 VUS of 87 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.45LOEUF
pLI 0.000
Z-score 0.17
OE 0.95 (0.651.45)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.16Z-score
OE missense 0.97 (0.871.08)
226 obs / 232.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.95 (0.651.45)
00.351.4
Missense OE0.97 (0.871.08)
00.61.4
Synonymous OE1.08
01.21.6
LoF obs/exp: 16 / 16.8Missense obs/exp: 226 / 232.7Syn Z: -0.59
DN
0.7230th %ile
GOF
0.77top 25%
LOF
0.2872th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

87 submitted variants in ClinVar

Classification Summary

Pathogenic19
Likely Pathogenic1
VUS61
19
Pathogenic
1
Likely Pathogenic
61
VUS

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
19
0
19
Likely Pathogenic
0
0
1
0
1
VUS
0
57
4
0
61
Likely Benign
0
0
0
0
0
Benign
0
0
0
0
0
Total05724081

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

QRFPR · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →